Complete tumor response. (A) Patient 09 at baseline, (B)stable disease atfirst follow-up, (C)partial response (PR) at second follow-up, (D) PR at 20 weeks from start of virotherapy, and (E and F) complete response at 25 and 30 weeks from start of virotherapy
Complete tumor response. (A) Patient 09 at baseline, (B)stable disease atfirst follow-up, (C)partial response (PR) at second follow-up, (D) PR at 20 weeks from start of virotherapy, and (E and F) complete response at 25 and 30 weeks from start of virotherapy